Panorama Capital backs CardioKinetix’s $48m Series E round


news_heartmonitor.lrgMedical devices maker CardioKinetix has successfully raised $48m via a Series E funding round, which was backed by new investor Panorama Capital.

Panorama joins the Menlo Park–based company’s existing investors such as US Venture Partners, JPMorgan Partners, New Leaf Venture Partners, SV Life Sciences, H&Q Healthcare Investors and H&Q Life Sciences Investors.

The new financing will be used for the ongoing development of Cardio’s catheter-based treatment for heart failure.

Rod Ferguson, managing director of Panorama Capital, said, “The combination of the heart failure market size, the growth of structural heart procedures, and the elegant design of the Parachute is a very attractive investment for our firm and we are excited to join the other investors and support CardioKinetix.”

Last October Panorama led a $10m Series D funding round for Skyfire, an investment that will help finance the US-based mobile video optimisation company’s plans to expand into Europe and Asia.

Copyright © 2013 AltAssets